
This shows you the differences between two versions of the page.
| Previous revision | |||
| — | home:publications:albert_autoimmunity_reviews_2009 [09.14.2022] (current) – external edit 127.0.0.1 | ||
|---|---|---|---|
| Line 1: | Line 1: | ||
| + | | ||
| + | |||
| + | **Type:** Paper\\ | ||
| + | **Authors: | ||
| + | **Publication: | ||
| + | **Citation: | ||
| + | |||
| + | |||
| + | < | ||
| + | |||
| + | <a href=" | ||
| + | </ | ||
| + | |||
| + | ===== Abstract ===== | ||
| + | |||
| + | |||
| + | |||
| + | Early studies on vitamin D showed promise that various forms of the “vitamin” may be protective against chronic disease, yet systematic reviews and longer-term studies have failed to confirm these findings. A number of studies have suggested that patients with autoimmune diagnoses are deficient in 25-hydroxyvitamin-D (25-D) and that consuming greater quantities of vitamin D, which further elevates 25-D levels, alleviates autoimmune disease symptoms. Some years ago, molecular biology identified 25-D as a secosteroid. Secosteroids would typically be expected to depress inflammation, | ||
| + | |||
| + | {{tag> | ||